Molbio Diagnostics

Molbio Diagnostics, an innovative point-of-care diagnostics company, has been awarded the KOCHON Prize 2024 by the Stop TB…

Collaboration to make early breast cancer detection accessible in India, Africa, Middle East, CIS countries, and Southeast Asia

Philippines–India partnership in health technology aims at advancing healthcare access and deepening bilateral relations

The new test covers eight high-risk HPV genotypes, including 52 and 58 — now detectable at the point-of-care

Despite challenges, diagnostics in tier 2 and 3 cities are growing through PPPs and technology adoption

Through this collaboration, Molbio Diagnostics aims to make EnViro-Q accessible worldwide, particularly in public health sectors,…

New appointments aim to strengthen healthcare accessibility through innovative diagnostics

The donated package includes the Prorad ATLAS Ultraportable X-ray and Truenat rapid molecular diagnostics platforms, complemented…

Partnership aims to expand AI-driven diagnostic solutions globally and improve healthcare access in underserved regions

The deployment of Truenat led to an increase in the TB case detection rate and the assays, which provide results within 60…